Kulvinder Kochar Kaur et al. 2020. Optimizing Cardiovascular Outcome in Type 2 Diabetes Mellitus with Better Control of Diabetes Mellitus with Empigliflozin and Hypertension with Renin Angiotensin System Inhibitors and Manidipine Preferably of the Dihydropyridones. Obesity Research. (Jan. 2020), 1–13. DOI:https://doi.org/10.17140/OROJ-7-141.